Industry
Samsung
Total Trials
4
Recruiting
2
Active
2
Completed
2
Success Rate
100.0%+13% vs avg
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
Failure Rate
0.0%
0 terminated/withdrawn out of 4 trials
Success Rate
100.0%
+13.5% vs industry average
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed trials have results
Key Signals
2 recruiting1 with results
Enrollment Performance
Analytics
N/A
2(100.0%)
2Total
N/A(2)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (4)
Showing 4 of 4 trials
NCT07226947Not ApplicableRecruiting
Body Composition and Exercise to Prevent Muscle Loss With GLP1 Agonist Treatment
Role: collaborator
NCT04703166Recruiting
Tulane iPredict, Prevent Study to Evaluate the Progression of Atrial Myopathy.
Role: collaborator
NCT03187132Not ApplicableCompleted
Development and Validation of a Digital Pain-Reduction Kit for Musculoskeletal Injuries
Role: collaborator
NCT02115425Completed
Calibrate Samsung's BIA to Meseaure Body Composition
Role: collaborator
All 4 trials loaded